Analyzing the potential regulation of ADAM expression in RB cell lines and patient tumors by miRNAs (miRs), in the study presented, miR-152, a miR discussed to target ADAM17 and regulate its expression in other cancer entities [51,72], was differentially expressed in the RB cell lines and in a subset of RB tumor samples investigated. This evidence concerns the gene ADAM17 and cancer.